Pharmaceutical Industry Information Portal

HomeDiscovery and Development

Discovery and Development

Sputnik V demonstrates strong safety profile during vaccination campaign in San Marino

San Marino was the first country in Europe to defeat COVID and lift restrictions thanks to inclusion of Sputnik V vaccine in the national portfolio.

Eleven children receive first dose of Sputnik V in Moscow

After the first and second shots of the vaccine, the teenagers will stay in hospital, in an isolated ward, for three days. Later, they will have to visit the hospital at intervals to undergo tests.

Servier and PRISM BioLab enter drug discovery collaboration for a novel target

Servier, a global independent pharmaceutical Group, and PRISM BioLab, a Japan based biotechnology company with proprietary small molecule drug discovery platform, “PepMetics™Technology”, today announced...

Russian Military Developing ‘Chewing Gum’ COVID-19 vaccine

A Russian military research unit that was involved in the development of Sputnik V is working on a new coronavirus vaccine in the form...

Vectura to provide preclinical support for Incannex’s inhaled brain injury treatment

IHL-216A may make sports safer and reduce the morbidity and mortality rates of people suffering serious head traumas.

Avifavir® for the treatment of COVID-19 is rated among Russia’s TOP 100 Inventions

Avifavir® became the world’s first approved favipiravir-based drug for COVID-19 infection treatment and the first drug against COVID-19 authorized in Russia.
spot_img

Expert Articles

spot_img